TLDR Using Favipiravir, a COVID-19 treatment drug, likely doesn't cause hair loss.
The study investigated the link between Favipiravir (FVP), a COVID-19 treatment drug, and Telogen Effluvium (TE), a common type of hair loss. It included patients aged 18-65 who had been diagnosed with COVID-19 in the past year and were experiencing hair loss. The results showed that the majority of FVP users were women (p = 0.027), and the rate of positive pull tests, used to diagnose TE, was significantly higher among those who did not use FVP (p = 0.026). This suggests that FVP may not influence the development of TE. This is the first study to explore the effect of FVP on alopecia and TE.View this study on dergipark.org.tr →